L’objet du CPER-ResistOmics est de structurer la recherche sur les maladies inflammatoires et infectieuses en particulier autour de la résistance aux traitements et des complications associées afin de proposer des solutions innovantes et personnalisées aux patients. L’ambition est de faire des Hauts-de-France un leader international en innovation thérapeutique au profit des malades atteints de pathologies inflammatoires et/ou infectieuses en créant un Centre pluridisciplinaire Inflammation-Infection.
The goal of the CPER ResistOmics is to federate the research on inflammatory and infectious diseases with a specific interest on the antibiotics resistance and the associated complication, in order to offer innovative and personalized solutions to the patients. Our ambition is to make the Hauts-de-France an international leader in in therapeutic innovation related to inflammatory and/or infectious pathologies by creating a multidisciplinary Inflammation-Infection Center.
Company Details
- Founded
- -
- Address
- Lille, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Lille
Cper Resistomics Questions
Cper Resistomics's website is https://static.lillemetropole.fr/deliberations/pdf/22_C_0350.PDF
Cper Resistomics's LinkedIn profile is https://fr.linkedin.com/company/cper-resistomics
Cper Resistomics's industry is
Biotechnology Research
Cper Resistomics's top competitors are
Cratb Pays De La Loire - Medqual,
Edyp Exploring The Dynamics Of Proteomes,
Réseau National Des Crb De Chu,
Lordil,
Cper Tecsante,
Gis Ibisa,
Connexine 2is,
Baxerna,
Ums_plbs,
Gdr Imabio.
Cper Resistomics's categories are Biotechnology Research
Cper Resistomics's founding year is 2021
